Dr. Jia Luo discusses how liquid and tumor biopsies compare, and how they are utilized in lung cancer treatment.

Click here to watch the full video: https://studio.youtube.com/video/PKqUDWWlXFQ/edit

#LungCancer #Typesofbiopsies #tumorbiopsies #Liquidbiopsies #LungCancer2024 #Lungcancerinfo #Lungcancereducation #cancerGRACE

YouTube

Share your videos with friends, family, and the world.

Evidence that #LiquidBiopsies are promoted but not rigorously tested: "Circulating tumor DNA tests are being promoted for multiple indications. Numerous studies are ongoing, but randomized clinical trials of their effect on patient-centered outcomes are rare." 2/4

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2808647

Assessing the Clinical Utility of Liquid Biopsies

This review assesses 5 clinical indications for molecular-based tests to detect and quantify tumor DNA circulating in the bloodstream among patients with suspected cancer or recurrence.

Please RT: #WeAreHiring - Exciting 2yr #postdoc on
@AlCRIproject
funded by
@hea_irl
on #liquidbiopsies (#CTCs #EV #ctDNA), #vibrationalspectroscopy (#Raman #FTIR) and #machinelearning for #cancer in collaboration with
@CluB_Cancer1
Deadline 24 July! https://euraxess.ie/jobs/122141
Post-Doctoral Researcher - AICRI project (Fixed-term specified purpose for up to 5 years, with initial funding available for 2 years) (Reference 137/2023)

Applications are invited for the following Post in the Technological University Dublin:  

EURAXESS
Post doctoral fellow

Post a job in 3min, or find thousands of job offers like this one at jobRxiv!

jobRxiv
Post doctoral fellow

Post a job in 3min, or find thousands of job offers like this one at jobRxiv!

jobRxiv

RT @pashtoonkasi: 🆕 Just published @NatureMedicine @Nature

Editorial on✍🏽
#LiquidBiopsies & the Tumor Mutational Burden cutoff conundrum.

🩸Blood-TMB or plasma-TMB cutoffs need to be harmonized; across platforms, & tissue🆚 liquid.

💡Thoughts?

#ESMO22
https://t.co/kCNQXsWvmy https://t.co/7PSeRahcjK

@oncology

Liquid biopsies and tumor mutational burden: the cutoff conundrum - Nature Medicine

Assessment of tumor mutational burden through a simple blood test could help to identify which patients are most likely to benefit from immunotherapy, but optimal cutoffs are not well established.

Nature
Just testing out for the first time so also time for my #introduction. I am a PostDoc working on lung #cancer and #liquidbiopsies and #biomarker development at the MD Anderson Cancer Center. Looking forward to meet new people here and learn how to use that network. Thanks to genomic.social for providing the server. #lcsm #science #cfDNA #NSCLC #SCLC #datascience